Rheumatoid arthritis and genetic markers in Syrian and French populations: Different effect of the shared epitope

Annals of the Rheumatic Diseases

Volumn 66, Issue 2, 2007, Pages 195-201

  Kazkaz, Leyla ^b   Marotte, Hubert ^a   Hamwi, Mayssa ^a   Cazalis, Marie Angélique ^a   Roy, Pascal ^c   Mougin, Bruno ^a   Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Teshreen Hospital   (Syrian Arab Republic)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INTERLEUKIN 1; INTERLEUKIN 1BETA; METHOTREXATE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; FRANCE; GENE DOSAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYRIAN ARAB REPUBLIC;

ADULT; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; CASE-CONTROL STUDIES; CYTOKINES; EPITOPES; FEMALE; FRANCE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SYRIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846884241     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.033829     Document Type: Article

References (39)

1. Wakitani S, Murata N, Toda Y, Oaawa R, Kaneshige T, Nishimura Y, et al. The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. Br J Rheumatol 1997;36:630-6.
2. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-7.
3. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
4. Kochi Y, Yamada R, Kobavashi K, Takahashi A, Suzuki A, Sekine A, et al. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum 2004;50:63-71.
5. Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998;95:10746- 50.
6. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001;68:927-36.
7. Brennan FM, Maini RN, Feldmann M. TNF alpha - a pivotal role in rheumatoid arthritis? Br J Rheumatol 1992;31:293-8.
8. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
9. Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun 2001;2:222-8.
10. Vinasco J, Beraun Y, Nieto A, Fraile A, Mataran L, Pareja E, et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997;49:74-8.
11. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997;36:516-21.
12. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Buchs N, Silvestri T, di Giovine FS, Chabaud M, Vannier E, Duff GW, et al. IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology (Oxford) 2000;39:1126-31.
14. Mougin B, Garnero P, Borel O, Compagnon C, Barbalat V, Marotte H, et al. A routine assay for the direct analysis of HLA-DR-related shared epitope and B27 alleles in chronic inflammatory arthritis. J Immunol Methods 2001;256:47-53.
15. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taql polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur Clin Invest 1992;22:396-402.
16. Demeter J, Messer G, Ramisch S, Mee JB, di Giovine FS, Schmid M, et al. Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokines Mol Ther 1996;2:239-42.
17. Wickersham EA, Fike ML, Rousseau E, Boyer JT, Meredith KE, Cloy CA. Arthritis: preferred learning methods among Arizona therapists. Am J Occup Ther 1982;36:509-14.
18. Reveille JD, Alarcon GS, Fowler SE, Pillemer SR, Neuner R, Clegg DO, et al. HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum 1996;39:1802-7.
19. Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and - DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 1996;55:34-9.
20. Thomson W, Harrison B, Ollier B, Wiles N, Payton T, Barrett J, et al. Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum 1999;42:757-62.
21. Mattey DL, Hassell AB, Dawes PT, Cheung NT, Poulton KV, Thomson W, et al. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2001;44:1529-33.
22. Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum 2002;46:2320-9.
23. Balsa A, Minaur NJ, Pascual-Salcedo D, McCabe C, Balas A, Fiddament B, et al. Class II MHC antigens in early rheumatoid arthritis in Bath (UK) and Madrid (Spain). Rheumatology (Oxford) 2000;39:844-9.
24. Hameed K, Bowman S, Kondeatis E, Vaughan R, Gibson T. The association of HLA-DRB genes and the shared epitope with rheumatoid arthritis in Pakistan. Br J Rheumatol 1997;36:1184-8.
25. Nichol FE, Woodrow JC. HLA DR antigens in Indian patients with rheumatoid arthritis. Lancet 1981;1:220-1.
26. Ollier WE, Stephens C, Awad J, Carthy D, Gupta A, Perry D, et al. Is rheumatoid arthritis in indians associated with HLA antigens shoring a DR beta 1 epitope? Ann Rheum Dis 1991;50:295-7.
27. Taneja V, Giphart MJ, Verduijn W, Naipal A, Malaviya AN, Mehra NK. Polymorphism of HLA-DRB, -DQA1, and -DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001. Hum Immunol 1996;46:35-41.
28. Mody GM, Meyers OL. Therapeutic requirements in rheumatoid arthritis. S Afr Med J 1990;77:497-9.
29. Boki KA, Drosos AA, Tzioufas AG, Lanchbury JS, Panayi GS, Moutsopoulos HM. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann Rheum Dis 1993;52:517-19.
30. Yelamos J, Garcia-Lozano JR, Moreno I, Aguilera I, Gonzalez MF, Garcia A, et al. Association of HLA-DR4-Dw15 (DRB1 *0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 1993;36:811-14.
31. Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, et al. ICF core sets for rheumatoid arthritis. J Rehabil Med 2004;(Suppl):87-93.
32. Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicily on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 2004;50:400-12.
33. Kakimoto K, Matsukawa A, Yoshinaga M, Nakamura H. Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. Cell Immunol 1995;165:26-32.
34. Koh WH, Chan SH, Lin YN, Boey ML. Association of HLA-DRB1 *0405 with extraarticular manifestations and erosions in Singaporean Chinese with rheumatoid arthritis. J Rheumatol 1997;24:629-32.
35. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1 *0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995;22:1032-0.
36. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989;36:178-82.
37. Rigby AS, Silman AJ, Voelm L, Gregory JC, Ollier WE, Khan MA, et al. Investigating the HLA component in rheumatoid arthritis: an additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol 1991;8:153-75.
38. Hajeer AH, Worthington J, Silman AJ, Ollier WE. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04- bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996;39:1109-14.
39. Fabris M, Di PE, D'Elia A, Damante G, Sinigaglia L, Ferraccioli G. Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis. J Rheumatol 2002;29:29-33.